Log In
BCIQ
Print this Print this
 

TA-CIN

  Manage Alerts
Collapse Summary General Information
Company Cancer Research Technology Ltd.
DescriptionSubunit vaccine comprising L2/E6/E7 proteins from human papillomavirus (HPV) 16
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHuman papillomavirus (HPV)
Indication DetailsTherapeutic vaccination against human papillomavirus (HPV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today